Article

jdsupra.com on 2022-05-25 17:49

Ninth Circuit Affirms Dismissal Of Complaint Against Pharmaceutical Company For Failure To Allege Falsity And Loss Causation

On May 19, 2022, the United States Court of Appeals for the Ninth Circuit affirmed a district court’s dismissal of a putative class action against a ...

Related news

Eighth Circuit Affirms Dismissal Of Putative Securities Class Action For Failure To Adequately Allege Falsity And Scienter jdsupra.com
Plantation
Fifth Circuit Affirms Dismissal Of Securities Class Action For Failure To Adequately Allege Material Misstatements And Loss Causation jdsupra.com
California , United States , Switzerland , Whole Foods Market
First Circuit Affirms Dismissal Of Putative Class Action Against Pharmaceutical Company For Failure To Adequately Allege Scienter jdsupra.com
California , United States , Switzerland
Northern District Of Illinois Dismisses Putative Class Action Against Pharmaceutical Company For Failure To Adequately Allege Falsity Or Scienter jdsupra.com
California , United States , Switzerland , Georgetown Scott County Regional Airport
Eighth Circuit Affirms Dismissal Of Putative Class Action Against Major American Retailer For Failure To Adequately Plead Falsity And Scienter jdsupra.com
California , Switzerland , United States , Canada
Ninth Circuit Affirms Dismissal Of Exchange Act Claims Based On Omnicare's Standard For Falsity Of Opinion Statements jdsupra.com
Dearborn Heights
Ninth Circuit Upholds Dismissal With Prejudice Of Class Action Lawsuit Due To Failure To Sufficiently Allege Loss Causation And Scienter jdsupra.com
Manage
Fourth Circuit Affirms Dismissal Of Putative Class Action For Failure To Adequately Allege Scienter jdsupra.com
Northern District Of California Grants In Part Motion To Dismiss Securities Fraud Claims Against Multinational Technology Company, Holding That Plaintiffs Did Not Adequately Allege Falsity, Scienter, Or Loss Causation With Respect To Majority Of Alleged Misstatements jdsupra.com
China , Cranz , California
Fifth Circuit Affirms Dismissal Of Putative Securities Class Action Against Home Furnishings Retailer For Failure To Adequately Allege Scienter jdsupra.com
California , United States , Switzerland , Michigan , Texas
Second Circuit Affirms Dismissal Of Putative Class Action For Failure To Allege With Particularity Illegal Acts Underlying Alleged Misrepresentations jdsupra.com
California , United States , Switzerland , Sanderson
Fourth Circuit Affirms Dismissal Of Putative Class Action Against Biopharmaceutical Company For Failure To Allege Scienter And Materiality jdsupra.com
San Antonio
Ninth Circuit Affirms Dismissal Of Putative Class Action Against Medical Device Company For Failure To Adequately Allege Scienter jdsupra.com
Europe
Third Circuit Affirms Dismissal of Complaint, Finding Investors Failed to Sufficiently Allege Amarin’s Statements Were False or Misleading jdsupra.com
South Korea , United States , New York , California
Fifth Circuit Affirms Dismissal Of Class Action Against Pipeline Operator For Failure To Adequately Allege Misstatements Or Scienter jdsupra.com
California , United States , Switzerland , Detroit
Eleventh Circuit Affirms Dismissal Of Putative Class Action Against Medical Technology Company For Failure To Adequately Allege Misrepresentations jdsupra.com
United States
Northern District Of California Grants Motion To Dismiss Securities Fraud Claims Against Pharmaceutical Company, Finding That Plaintiffs Did Not Adequately Allege Falsity And Scienter With Respect To Alleged Material Omissions jdsupra.com
California , United States , Switzerland
Second Circuit Summarily Affirms Dismissal Of Putative Securities Fraud Class Action Against Pharmacy Benefits Manager Company, Finding That Plaintiffs Failed To Adequately Allege Material Misstatements And Scienter jdsupra.com
California , United States , Switzerland
Eleventh Circuit Affirms Dismissal Of Putative Class Action Against Direct-To-Consumer Marketing Company For Failure To Adequately Allege Scienter Or Scheme Liability jdsupra.com
Fourth Circuit Affirms Dismissal Of Securities Fraud Class Action Against Cancer Drug Manufacturer For Failure To Allege False Or Misleading Statements jdsupra.com
Safe Harbor